Cantourage Group SE
Produces and distributes EU-compliant medical cannabis from international partners.
HIGH | XMIL
Overview
Corporate Details
- ISIN(s):
- DE000A3DSV01
- LEI:
- 3912003NCTLO6YHA9V48
- Country:
- Germany
- Address:
- Feurigstraße 54, 10827 Berlin
- Website:
- https://www.cantourage.com/
- Sector:
- Manufacturing
Description
Cantourage Group SE is a company specializing in the production and distribution of medical cannabis. It operates a platform that enables global cultivators to access the European market by managing the import, processing, and distribution of cannabis products. The company processes raw materials from its international partners into EU-compliant finished medicinal products, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Its portfolio features a diverse range of cannabis strains. Additionally, Cantourage operates the 'Telecan' telemedicine platform to facilitate patient access to cannabis-based therapies. The company's strategy involves developing new cannabis medicines and working to lower the cost of treatment for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-19 14:39 |
Cantourage Group SE expects EBITDA for 2025 to exceed current market expectatio…
|
English | 5.2 KB | ||
| 2025-12-09 08:00 |
Cantourage appoints new member to its Management Board: Monique Jaqqam becomes …
|
English | 9.2 KB | ||
| 2025-11-04 12:00 |
Cantourage strengthens market presence in Poland with flower variety Gelato 33
|
English | 10.7 KB | ||
| 2025-10-30 10:08 |
Q3 2025: Cantourage delivers strong operating performance in a challenging regu…
|
English | 9.7 KB | ||
| 2025-10-15 15:49 |
Cabinet decision on the Medical Cannabis Act meets broad criticism / Cantourage…
|
English | 13.0 KB | ||
| 2025-10-08 13:01 |
Cantourage is responding to potential developments resulting from new legal reg…
|
English | 8.3 KB | ||
| 2025-10-01 09:47 |
Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations…
|
English | 7.4 KB | ||
| 2025-10-01 09:39 |
Cantourage Group SE: Philip Schetter, Acquisition of 188,639 Shares as Part of …
|
English | 6.1 KB | ||
| 2025-09-04 09:00 |
Cantourage Group SE Update
|
German | 12.5 KB | ||
| 2025-07-09 18:42 |
Ad-hoc-Mitteilung nach Art. 17 Marktmissbrauchsverordnung - Cantourage Group SE…
|
German | 4.6 KB | ||
| 2025-05-20 07:51 |
Cantourage achieves strong and profitable growth in the first quarter of 2025
|
English | 7.4 KB | ||
| 2025-05-15 07:07 |
Cantourage achieves another record revenue: EUR 11.1 million in April 2025
|
English | 6.6 KB | ||
| 2025-04-11 09:03 |
Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 202…
|
English | 6.8 KB | ||
| 2025-04-10 08:52 |
Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 for the fi…
|
English | 9.0 KB | ||
| 2025-03-11 08:31 |
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
|
German | 7.6 KB |
Automate Your Workflow. Get a real-time feed of all Cantourage Group SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cantourage Group SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cantourage Group SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-02 | Think.Health Projekt M GmbH & Co. KG | Close relation | Sell | None | 72,010.80 EUR |
| 2024-11-25 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 200,000.00 EUR |
| 2024-09-13 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 105,000.00 EUR |
| 2024-07-18 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 140,000.00 EUR |
| 2024-06-06 | HOFY4 GmbH | Close relation | Sell | None | 345,000.00 EUR |
| 2024-05-27 | HOFY4 GmbH | Close relation | Sell | None | 7,400.00 EUR |
| 2024-05-17 | HOFY4 GmbH | Close relation | Sell | None | 140,000.00 EUR |
| 2024-05-17 | HOFY4 GmbH | Close relation | Sell | None | 1,080.00 EUR |
| 2024-02-21 | HOFY4 GmbH | Close relation | Sell | None | 63,205.88 EUR |
| 2024-02-14 | Think.Health Projekt M GmbH & Co. KG | Close relation | Sell | None | 82,415.57 EUR |
Peer Companies
